173 related articles for article (PubMed ID: 23777494)
1. Treatment of Darier disease with oral alitretinoin.
Letulé V; Herzinger T; Ruzicka T; Molin S
Clin Exp Dermatol; 2013 Jul; 38(5):523-5. PubMed ID: 23777494
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment with oral alitretinoin in women of childbearing potential with Darier's disease.
Zamiri M; Munro CS
Br J Dermatol; 2013 Sep; 169(3):709-10. PubMed ID: 23551220
[No Abstract] [Full Text] [Related]
3. [Successful treatment of Darier disease with oral alitretinoin].
Barnstedt SE
Hautarzt; 2012 Feb; 63(2):139-41. PubMed ID: 21761212
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of alitretinoin in the treatment of Darier disease: a case report.
Pagon A; Dolenc Voljč M
Acta Dermatovenerol Alp Pannonica Adriat; 2023 Dec; 32(4):191-195. PubMed ID: 38126103
[TBL] [Abstract][Full Text] [Related]
5. Oral alitretinoin: a review of the clinical pharmacokinetics and pharmacodynamics.
Schmitt-Hoffmann AH; Roos B; Schoetzau A; Leese PT; Meyer I; van de Wetering J; Kovacs P
Expert Rev Clin Pharmacol; 2012 Jul; 5(4):373-88. PubMed ID: 22943117
[TBL] [Abstract][Full Text] [Related]
6. Alitretinoin and acitretin in severe chronic hand eczema; results from a retrospective daily practice study.
Politiek K; Christoffers WA; Coenraads PJ; Schuttelaar MA
Dermatol Ther; 2016 Sep; 29(5):364-371. PubMed ID: 27146260
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial.
Ruzicka T; Lynde CW; Jemec GB; Diepgen T; Berth-Jones J; Coenraads PJ; Kaszuba A; Bissonnette R; Varjonen E; Holló P; Cambazard F; Lahfa M; Elsner P; Nyberg F; Svensson A; Brown TC; Harsch M; Maares J
Br J Dermatol; 2008 Apr; 158(4):808-17. PubMed ID: 18294310
[TBL] [Abstract][Full Text] [Related]
8. Extended treatment with oral alitretinoin for patients with chronic hand eczema not fully responding to initial treatment.
Lynde C; Cambazard F; Ruzicka T; Sebastian M; Brown TC; Maares J
Clin Exp Dermatol; 2012 Oct; 37(7):712-7. PubMed ID: 22731739
[TBL] [Abstract][Full Text] [Related]
9. Alitretinoin: A Review in Severe Chronic Hand Eczema.
Blair HA; Scott LJ
Drugs; 2016 Sep; 76(13):1271-1279. PubMed ID: 27438290
[TBL] [Abstract][Full Text] [Related]
10. A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of alitretinoin (BAL4079) in the treatment of severe chronic hand eczema refractory to potent topical corticosteroid therapy.
Fowler JF; Graff O; Hamedani AG
J Drugs Dermatol; 2014 Oct; 13(10):1198-204. PubMed ID: 25607554
[TBL] [Abstract][Full Text] [Related]
11. [Response to treatment with oral alitretinoin in patients with chronic hand eczema that is refractory to treatment with potent topical corticosteroids: experience in 15 patients].
Aguayo-Leiva IR; Urrutia S; Jaén-Olasolo P
Actas Dermosifiliogr; 2011 Oct; 102(8):616-22. PubMed ID: 21354545
[TBL] [Abstract][Full Text] [Related]
12. Impact of systemic alitretinoin treatment on skin barrier gene and protein expression in patients with chronic hand eczema.
Kumari V; Timm K; Kühl AA; Heine G; Worm M
Br J Dermatol; 2016 Dec; 175(6):1243-1250. PubMed ID: 27480504
[TBL] [Abstract][Full Text] [Related]
13. Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema.
Bissonnette R; Worm M; Gerlach B; Guenther L; Cambazard F; Ruzicka T; Maares J; Brown TC
Br J Dermatol; 2010 Feb; 162(2):420-6. PubMed ID: 19906075
[TBL] [Abstract][Full Text] [Related]
14. [Darier-White disease treated with oral isotretinoin].
Eimer L; Lagodin C; Bonavia P; Stringa M; Rébora I; Anaya J
Arch Argent Pediatr; 2011 Aug; 109(4):e63-6. PubMed ID: 21829859
[TBL] [Abstract][Full Text] [Related]
15. Nail improvement during alitretinoin treatment: three case reports and review of the literature.
Milanesi N; D'Erme AM; Gola M
Clin Exp Dermatol; 2015 Jul; 40(5):533-6. PubMed ID: 25682921
[TBL] [Abstract][Full Text] [Related]
16. An open-label study assessing the safety and efficacy of alitretinoin in patients with severe chronic hand eczema unresponsive to topical corticosteroids.
Dirschka T; Reich K; Bissonnette R; Maares J; Brown T; Diepgen TL
Clin Exp Dermatol; 2011 Mar; 36(2):149-54. PubMed ID: 21070335
[TBL] [Abstract][Full Text] [Related]
17. Influence of alitretinoin on the pharmacokinetics of the oral contraceptive ethinyl estradiol/norgestimate.
Schmitt-Hoffmann AH; Roos B; Sauer J; Schleimer M; Schoetzau A; Leese PT; Weidekamm E; Maares J
Clin Exp Dermatol; 2011 Apr; 36 Suppl 2():4-11. PubMed ID: 21443598
[TBL] [Abstract][Full Text] [Related]
18. Acral Hemorrhagic Darier Disease.
Flores-Terry MÁ; García-Arpa M; Llamas-Velasco M; Mendoza-Chaparro C; Ramos-Rodríguez C
Actas Dermosifiliogr; 2017 Sep; 108(7):e49-e52. PubMed ID: 28407871
[TBL] [Abstract][Full Text] [Related]
19. Influence of food on the pharmacokinetics of oral alitretinoin (9-cis retinoic acid).
Schmitt-Hoffmann AH; Roos B; Sauer J; Schleimer M; Kovācs P; Stoeckel K; Maares J
Clin Exp Dermatol; 2011 Apr; 36 Suppl 2():18-23. PubMed ID: 21443600
[TBL] [Abstract][Full Text] [Related]
20. [Off-label use of alitretinoin].
Fritz K; Tiplica GS; Salavastru C; Onder M
Hautarzt; 2013 Oct; 64(10):748-51. PubMed ID: 24150823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
